Is TAVR for me?
Any patient diagnosed with severe aortic stenosis that is deemed inoperable for open aortic valve replacement can be referred for TAVR evaluation. All potential candidates seen for evaluation will be educated and assessed by the St. John’s Hospital team that includes a multidisciplinary group of interventional cardiologists and heart surgeons.
Up to 1.5 million people in the United States suffer from aortic stenosis. Severe stenosis — affecting about 250,000 Americans — causes narrowing or obstruction of the aortic valve and is most often caused by accumulation of calcium deposits on the valve leaflets, or flaps.
Patients with severe aortic valve narrowing — or stenosis — often suffer from extreme shortness of breath, chest pain, fatigue, and rapid or irregular heartbeat. Victims also can have “passing-out” spells and some die suddenly.
About two-thirds of the 250,000 Americans with severe stenosis undergo surgical replacement of their aortic valves each year. Many others aren’t treated because they are too sick for surgery, haven’t received a definitive diagnosis, or delay or decline the procedure. For those patients, TAVR represents an alternative.